
IPO
ANRO.NYSE
Past
Alto Neuroscience
Biotechnology
Company websiteTicker
ANRO.NYSE
Market
us
IPO date
2/1/2024
About
Engaged in the development of treatment methods for diseases related to the nervous system and the brain. The company operates in a highly demanded segment. The global market for antidepressant drugs and treatment methods is expected to grow to $16.8 billion by 2032 from the current $10.1 billion.
_____________________________
Headquarters:
369 South San Antonio Road, Los Altos, CA 94022, USA